(Hypertension. 2000;36:543.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
Differentiated Response of the Sympathetic Nervous System to Angiotensin-Converting Enzyme Inhibition in Hypertension
From the Departments of Clinical Physiology (M.J., P.F.), Clinical Neurophysiology (M.E.), Cardiology (B.R.), and Nephrology (H.H., G.J.), Göteborg University, Sahlgrenska University Hospital, Göteborg, Sweden; and National Institutes of Neurological Disorders and Stroke, Bethesda, Md (G.E.).
Correspondence to Mats Johansson, MD, PhD, Department of Clinical Physiology, Sahlgrenska University Hospital, SE 413 45 Göteborg, Sweden. E-mail m.johansson{at}medfak.gu.se
Abstract—Hypertension with renal artery stenosis is associated with both an activated renin-angiotensin system and elevated sympathetic activity. Therefore, in this condition it may be favorable to use a therapeutic modality that does not reflexly increase heart rate, renin secretion, and sympathetic nervous activity. The purpose of the present study was to assess overall, renal, and muscle sympathetic activity after short-term administration of an angiotensin-converting enzyme inhibitor (enalaprilat) and a nonspecific vasodilator (dihydralazine) to hypertensive patients with renal artery stenosis. Forty-eight patients undergoing a clinical investigation for renovascular hypertension were included in the study. An isotope dilution technique for assessing norepinephrine spillover was used to estimate overall and bilateral renal sympathetic nerve activity. In 11 patients simultaneous intraneural recordings of efferent muscle sympathetic nerve activity were performed. Thirty minutes after dihydralazine administration, mean arterial pressure fell by 15%, whereas plasma angiotensin II, muscle sympathetic nerve activity, heart rate, and total body norepinephrine spillover increased (P<0.05 for all). In contrast, after enalaprilat administration a fall in arterial pressure similar to that for dihydralazine was followed by decreased angiotensin II levels and unchanged muscle sympathetic nerve activity, heart rate, and total body norepinephrine spillover, whereas renal norepinephrine spillover increased by 44% (P<0.05). Acute blood pressure reduction by an angiotensin-converting enzyme inhibitor provokes a differentiated sympathetic response in patients with hypertension and renal artery stenosis, inasmuch that overall and muscle sympathetic reflex activation are blunted, whereas the reflex renal sympathetic response to blood pressure reduction is preserved.
Key Words: hypertension, renovascular • sympathetic nervous system • renin-angiotensin system
This article has been cited by other articles:
 |
|
 |
|
  M. Petersson, P. Friberg, G. Lambert, and B. Rundqvist Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure Eur J Heart Fail, October 1, 2005; 7(6): 1003 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Grisk and R. Rettig Interactions between the sympathetic nervous system and the kidneys in arterial hypertension Cardiovasc Res, February 1, 2004; 61(2): 238 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. DiBona The Sympathetic Nervous System and Hypertension: Recent Developments Hypertension, February 1, 2004; 43(2): 147 - 150. [Full Text] [PDF]
|
|
|
|
|
|
T. W. Lameris, S. de Zeeuw, D. J. Duncker, G. Alberts, F. Boomsma, P. D. Verdouw, and A. H. van den Meiracker Exogenous Angiotensin II Does Not Facilitate Norepinephrine Release in the Heart Hypertension, October 1, 2002; 40(4): 491 - 497. [Abstract] [Full Text] [PDF]
|
|